Amanote Research

Amanote Research

    RegisterSign In

NK Cell-Based Glioblastoma Immunotherapy

Cancers - Switzerland
doi 10.3390/cancers10120522
Full Text
Open PDF
Abstract

Available in full text

Categories
Cancer ResearchOncology
Date

December 18, 2018

Authors
Irene GolánLaura Rodríguez de la FuenteJose Costoya
Publisher

MDPI AG


Related search

NK Cell Metabolism and TGFβ – Implications for Immunotherapy

Frontiers in Immunology
AllergyImmunology
2019English

Dendritic Cell-Based Immunotherapy

Cell Research
Cell BiologyMolecular Biology
2016English

Human Embryonic Stem Cell (hESC)-derived NK Cells for Cancer Immunotherapy

Science-Business eXchange
2009English

T-Cell Apoptosis in Human Glioblastoma Multiforme: Implications for Immunotherapy

Journal of Neuroimmunology
AllergyImmunologyNeurology
2006English

Chimeric Antigen Receptor T-Cell Immunotherapy for Glioblastoma: Practical Insights for Neurosurgeons

Neurosurgical Focus
MedicineSurgeryNeurology
2018English

Cell Death-Based Treatment of Glioblastoma

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2018English

The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2019English

Current Studies of Immunotherapy on Glioblastoma

Journal of Neurology and Neurosurgery
2014English

Natural Killer T Cell Based Immunotherapy

Journal of Vaccines & Vaccination
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy